Clinical Trials Browser

Phase 3 × HBI-8000 × 90 days × Clear all

NCT07493109 2026-03-25

Chidamide for Maintenance Treatment of HBV-infected Diffuse DLBCL in Patients Initially Treated With R-CHOP

Phase 3 Recruiting

Lymphoma, Large B-Cell, Diffuse